Digital How biotech can leverage scientific enterprise SaaS By considering how to build a solid data foundation from the beginnings, smaller start-ups or biotechs can make sure they are ready to go.
Digital Cyber resilience: Protecting tomorrow's therapies before the... As investors place increasing emphasis on operational maturity alongside scientific excellence, cyber resilience must become part of the conversation.
Market Access Approval designed from day one: Building global-ready regula... The global pharmaceutical landscape is increasingly defined by the necessity for clinical acceleration without compromising data integrity.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.